SLC2A3 and colorectal carcinoma: In the current study, a positive correlation was found between high expression levels of glucose transporters (i.e., GLUT1, GLUT3, GLUT4, and SGLT1) and refractory to adjuvant FOLFOX chemotherapy in CRC patients.